Journal
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
Volume 5, Issue 5, Pages 489-500Publisher
INFORMA HEALTHCARE
DOI: 10.1517/17425250902911463
Keywords
drug transport; drug-drug interaction; OATP; OCT; organic anion transport; organic cation transport
Funding
- Deutsche Forschungsgemeinschaft [DFG Ko 2120/1-3, DFG Fr 1298/5-1]
- Deutsche Krebshilfe [107854]
Ask authors/readers for more resources
Background: Transport proteins, for example the drug export pump P-glycoprotein, are important for the absorption, distribution and excretion of drugs. Inhibition and induction of P-glycoprotein efflux function is a well-established mechanism of drug-drug interactions. Alteration of transporter-mediated drug uptake by concomitantly administered drugs may also result in a change in drug pharmacokinetics. These uptake transporter-mediated drug-drug interactions are the focus of this review. Objective: To examine the current in vitro evidence on interactions mediated by OATPs (organic anion transporting polypepticles) and OCTs (organic cation transporters). Methods: Comparing data of in vivo observed drug-drug interactions with in vitro analysed alterations in drug transport mediated by the hepatic expressed uptake transporters OATP1B1, OATP1B3 and OCT1 and by the renal expressed OCT2 protein. Results/conclusions: Some of the previously in vivo described drug-drug interactions could be explained by alteration in uptake transporter function demonstrating that inhibition or induction of uptake transporters is a newly recognised mechanism of potential drug-drug interactions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available